|

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

RECRUITINGPhase 1/2Sponsored by Vironexis Biotherapeutics Inc.
Actively Recruiting
PhasePhase 1/2
SponsorVironexis Biotherapeutics Inc.
Started2025-05-30
Est. completion2027-06
Eligibility
Age13 Years – 90 Years
Healthy vol.Accepted
Locations9 sites
View on ClinicalTrials.gov →

NCT06533579

Summary

This is a Phase 1/2, first-in-human, open-label, dose-escalating trial designed to assess the safety and efficacy of VNX-101 in patients with relapsed or refractory CD19-positive hematologic malignancies.

Eligibility

Age: 13 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age: Part 1: 18-90 years of age, Part 2: 13-90 years of age
* Relapsed or refractory CD-19 positive leukemia or lymphoma as defined in the protocol
* CD19-positive expression
* AAV specified capsid total antibody \<1:400
* Protocol-specified ranges for renal, liver, cardiac and pulmonary function
* Protocol-specified ranges for hematology parameters

Exclusion Criteria:

* Hepatoxicity (AST or ALT \> 2x upper limit of normal)
* History of thrombotic microangiopathy or cardiomyopathy, or evidence of sensory neuropathy
* Pregnant or nursing (lactating) women
* Acute Graft versus Host Disease (GvHD): Grade 2-4 or chronic GvHD of any grade
* History of hypersensitivity to corticosteroids or history of corticosteroid-related toxicity
* Chemotherapy given within the protocol-specified discontinuation timelines

Other Inclusion/Exclusion criteria to be applied per protocol.

Conditions14

B-cell Acute Lymphoblastic LeukemiaBurkitt LymphomaCancerChronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaFollicular LymphomaHigh-grade B-cell LymphomaLarge B-cell LymphomaMantle Cell LymphomaMarginal Zone Lymphoma

Locations9 sites

City of Hope
Duarte, California, 91010
Anthony Stein, MD877-467-3411AStein@coh.org
Valkyrie Clinical Trials
Los Angeles, California, 90067
Myo Zaw424-535-1874clinicaltrials@vctcare.com
Colorado Blood Cancer Institute
Denver, Colorado, 80218
Clinical Trial Information Line720-754-4835
New York Medical College
Valhalla, New York, 10595
Mitchell Cairo, MD914-594-2150mitchell_cairo@nymc.edu
University of North Carolina at Chapel Hill/ University of North Carolina Medical Center
Chapel Hill, North Carolina, 27599
Lacey Williams, MD919-445-9676Lacey_Williams@med.unc.edu

Find trials near these locations

Cancer trials in Los AngelesCancer trials in DenverCancer trials in ColumbusCancer trials in PortlandCancer trials in NashvilleCancer trials in HoustonAll trials in CaliforniaAll trials in ColoradoAll trials in New YorkAll trials in North CarolinaAll trials in OhioAll trials in OregonAll trials in TennesseeAll trials in Texas

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.